Integrum AB (OSTO:INTEG B) Debt-to-EBITDA : (As of Jul. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:INTEG B Integrum AB OSTO:INTEG B
59 GF Score
Price kr9.35
GF Value kr15.63
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Integrum AB Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Integrum AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jul. 2026 was kr1.80 Mil. Integrum AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jul. 2026 was kr0.94 Mil. Integrum AB's annualized EBITDA for the quarter that ended in Jul. 2026 was kr15.35 Mil. Integrum AB's annualized Debt-to-EBITDA for the quarter that ended in Jul. 2026 was 0.18.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Integrum AB's Debt-to-EBITDA or its related term are showing as below:

OSTO:INTEG B' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -2   Med: -0.13   Max: 0.73
Current: -0.1

During the past 12 years, the highest Debt-to-EBITDA Ratio of Integrum AB was 0.73. The lowest was -2.00. And the median was -0.13.

OSTO:INTEG B's Debt-to-EBITDA is ranked worse than
100% of 471 companies
in the Medical Devices & Instruments industry
Industry Median: 1.64 vs OSTO:INTEG B: -0.10

Integrum AB  (OSTO:INTEG B) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Integrum AB Debt-to-EBITDA Related Terms


Integrum AB Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Integrum AB's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integrum AB Debt-to-EBITDA Chart

Integrum AB Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Integrum AB Quarterly Data
Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26 Jul26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

OSTO:INTEG B vs ABT, SYK, MDT: Debt-to-EBITDA Comparison

For the Medical Devices subindustry, Integrum AB's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integrum AB Debt-to-EBITDA vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integrum AB's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Integrum AB's Debt-to-EBITDA falls into.


OSTO:INTEG B
59GF Score
Integrum AB OSTO:INTEG B
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integrum AB Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Integrum AB's Debt-to-EBITDA for the fiscal year that ended in Apr. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.773 + 1.398) / -41.187
=-0.08

Integrum AB's annualized Debt-to-EBITDA for the quarter that ended in Jul. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.799 + 0.939) / 15.352
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jul. 2026) EBITDA data.

Is Integrum AB (OSTO:INTEG B) Overvalued in 2026?

Based on GuruFocus' analysis, Integrum AB stock appears to be undervalued. The current stock price of kr9.35 is trading 40.2% below its estimated GF Value™ of kr15.63. GuruFocus considers Integrum AB to be Possible Value Trap.

Key valuation signals for OSTO:INTEG B:

  • Debt-to-EBITDA:
  • GF Value™: kr15.63 vs. price of kr9.35 (40.2% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the OSTO:INTEG B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Integrum AB Business Description

Other Exchanges 6Y1:Germany
Address Krokslatts Fabriker 50, Molndal, SWE, SE-431 37
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.
59GF Score

Get the complete analysis for OSTO:INTEG B

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr9.35
Price
kr15.63
GF Value